Influence of Concomitant Opioids on Difelikefalin Treatment Outcomes in Adults with Moderate-to-Severe Pruritus on Maintenance Hemodialysis: Exploratory Analyses
Kidney and Blood Pressure Research · 2025
DOI: 10.1159/000549648 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift Kidney and Blood Pressure Research, 2025. Verfasst von James O Burton und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Sciences, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, UK, jb343@le.ac.uk. Hauptthemen laut MEDLINE: Pruritus, Renal Dialysis, Analgesics, Opioid. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Difelikefalin (DFK) is approved to treat chronic kidney disease-associated pruritus (CKD-aP) in adults undergoing maintenance hemodialysis. The influence of concomitant opioid use on DFK treatment outcomes remains uncertain.
Methods
Exploratory analyses were conducted from the phase 3, placebo (PBO)-controlled KALM-1 and KALM-2 trials (datasets pooled), and the phase 3, open-label, single-arm Study 3105. Each trial assessed the safety and efficacy of DFK 0.5 µg/kg in adults with moderate-to-severe CKD-aP. We report key endpoints from the primary studies, including reduction in itch intensity (Worst Itching Intensity Numerical Rating Scale [WI-NRS]), and improvements in itch-related quality of life (QoL; 5-D itch and Skindex-10), according to concomitant opioid use (+O or −O).
Results
In KALM-1/KALM-2, 24.2% of participants on DFK and 30.4% on PBO were taking concomitant opioids. Regardless of opioid use, a greater estimated percentage of those receiving DFK achieved ≥3- or ≥4-point clinically relevant reductions in itch intensity (WI-NRS; p < 0.05), or complete response (≥80% weekly mean WI-NRS scores of 0 or 1) by week 12, versus PBO. Greater improvements in itch-related QoL were also reached with DFK, versus PBO, irrespective of concomitant opioid use. With either treatment, nonfatal serious TEAEs were more common among concomitant opioid users (DFK+O: 44.7% vs. DFK−O: 19.0%; PBO+O: 38.0% vs. PBO−O: 15.9%), as were severe TEAEs. In Study 3105, 31% were taking concomitant opioids.
Conclusion
DFK reduced itch intensity and improved QoL, regardless of concomitant opioid use. Similar concomitant opioid-dependent safety findings were observed. With or without concomitant opioid use, DFK demonstrated considerable efficacy that improved QoL. Increased TEAEs with concomitant opioid use with either treatment suggests careful medication management is advisable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Sciences, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, UK, jb343@le.ac.uk.
- Clean Slate Centers, Bethlehem, Pennsylvania, USA.
- CSL Vifor, Glattbrugg, Switzerland.
- Cara Therapeutics, Stamford, Connecticut, USA.
- Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.
Zitieren
APA
Burton, J. O., Grewal, S., Schaufler, T., Ruessmann, D., Lowe, M., Wen, W., & Fishbane, S. (2025). Influence of Concomitant Opioids on Difelikefalin Treatment Outcomes in Adults with Moderate-to-Severe Pruritus on Maintenance Hemodialysis: Exploratory Analyses. Kidney and Blood Pressure Research. https://doi.org/10.1159/000549648
Vancouver
Burton JO, Grewal S, Schaufler T, Ruessmann D, Lowe M, Wen W, et al. Influence of Concomitant Opioids on Difelikefalin Treatment Outcomes in Adults with Moderate-to-Severe Pruritus on Maintenance Hemodialysis: Exploratory Analyses. Kidney and Blood Pressure Research. 2025. doi:10.1159/000549648
BibTeX
@article{Burton2025,
author = {Burton, James O and Grewal, Satkiran and Schaufler, Thilo and Ruessmann, Despina and Lowe, Murray and Wen, Warren and Fishbane, Steven},
title = {Influence of Concomitant Opioids on Difelikefalin Treatment Outcomes in Adults with Moderate-to-Severe Pruritus on Maintenance Hemodialysis: Exploratory Analyses},
journal = {Kidney and Blood Pressure Research},
year = {2025},
doi = {10.1159/000549648}
}
EUVIMED